Village Farms demonstrates a solid core business model centered on controlled environment cannabis cultivation with defensible operational advantages in greenhouse asset utilization and international regulatory compliance. Its recent margin expansion and international export growth validate strateg…
Village Farms International (VFF) Q2 2025: Canadian Cannabis Margins Surge to 39% Amid International Expansion
Village Farms capitalized on a strategic produce asset privatization and robust international cannabis sales to deliver record profitability and margin expansion in Q2 2025. The company’s disciplined supply management and targeted portfolio realignment underpin strong gross margins, while capacity expansions in Canada and the Netherlands position it for sustained growth. Investors should monitor execution on expansion and regulatory developments in the US cannabis market as key future catalysts.
Summary
- Margin Leadership: Canadian cannabis gross margin reached 39%, the highest in three years.
- International Growth Acceleration: Export sales surged 690% year-over-year, driving top-line and margin expansion.
- Strategic Capacity Expansion: Approved Delta II greenhouse conversion and Netherlands Phase II facility set stage for 2026 growth.
Business Overview
Village Farms International operates as a vertically integrated controlled environment agriculture company, primarily focused on cannabis cultivation and sales across Canada, the US, and Europe. Its major segments include Canadian cannabis, US cannabis (Balanced Health Botanicals), Netherlands cannabis (Leli Holland), and a legacy produce business that was partly privatized in Q2 2025. Revenue is generated through wholesale and retail branded cannabis sales, international exports, and produce operations.
Performance Analysis
Village Farms reported consolidated net sales of $59.9 million, a 12% increase year-over-year, driven largely by the Canadian cannabis segment and the first full quarter of recreational cannabis sales in the Netherlands. Adjusted EBITDA from continuing operations soared to $17.1 million, representing 28.6% of sales, a record margin expansion of over 2,300 basis points compared to the prior year. This profitability milestone underscores the company’s successful realignment toward higher-margin SKUs and disciplined supply management amid evolving market dynamics.
Canadian cannabis sales rose 10% in Canadian dollars to C$61.4 million, propelled by a remarkable 690% increase in international export sales. While retail branded sales declined 20% due to a planned shift away from low-margin SKUs, the gross margin improved significantly to 39%, reflecting a more profitable product mix and favorable wholesale channel dynamics. The Netherlands operation contributed $2.5 million in sales with a $1.2 million adjusted EBITDA, demonstrating early-stage profitability. The US cannabis business stabilized with improved gross margin of 63%, achieving a modest positive adjusted EBITDA amid regulatory headwinds. The produce segment, now partly privatized, showed modest growth and a vendor settlement that improved adjusted EBITDA to $6.4 million from continuing operations.
- Margin Expansion Driver: Shift to higher-margin international exports and optimized SKU portfolio.
- International Sales Momentum: Scaling in Germany, UK, and other markets with strong distributor partnerships.
- Operational Efficiency: Refinanced Canadian cannabis debt with improved terms supporting cash flow and growth.
The combination of strategic asset privatization, disciplined supply-demand matching, and expanding international footprint positions Village Farms for sustainable profitability and growth.
Executive Commentary
"Our second quarter results demonstrate the improving earnings potential of Village Farms and our continued success in scaling a profitable global cannabis enterprise... We are growing organically, profitably and generating positive free cash flow, and we believe the strength of our balance sheet will enable us the flexibility to make additional growth investments that will drive strong returns for shareholders."
Michael DiGilio, Chief Executive Officer
"Canadian cannabis gross margin was 39% up from 26% in Q2 last year and at the high end of our target range of 30 to 40%, which provides clear evidence of success in both growing higher margin international export sales and our focus on higher margin products in Canada."
Steve Ruffini, Chief Financial Officer
Strategic Positioning
1. Focused Product Mix Realignment
Village Farms deliberately reduced low-margin retail branded SKUs in Canada to enhance profitability, accepting a temporary sales decline in exchange for margin expansion. This strategy is validated by a gross margin increase to 39%, signaling improved product mix and pricing power especially in the wholesale channel.
2. International Market Penetration and Diversification
The company aggressively scaled international medical cannabis exports, increasing sales by 690% year-over-year, with strong growth in Germany and the UK. This diversification reduces dependence on the Canadian market and positions Village Farms as a global cannabis supplier leveraging its EU GMP certification and GACP compliance.
3. Asset Optimization via Produce Privatization
The privatization of approximately one-third of its produce assets generated $40 million in cash and a 37.9% equity stake in Vanguard Food LP, enabling Village Farms to focus capital and management attention on cannabis growth while retaining meaningful upside from produce operations.
4. Capacity Expansion with Controlled Capital Deployment
Village Farms approved a $10 million Canadian dollar investment to convert 550,000 square feet of its Delta II greenhouse to cannabis production, expected to add 40 metric tons of annual capacity by early 2027. Concurrently, the Netherlands Phase II facility is on track for Q1 2026 start, expected to quintuple production capacity, supporting international recreational market growth.
5. Prudent Financial Management and Debt Refinancing
The company refinanced its Canadian cannabis term loans into a single facility with a lower variable interest rate below 6%, improving financial covenants and extending maturity to 2028. This enhances liquidity and financial flexibility to support organic growth and potential strategic acquisitions.
Key Considerations
Village Farms is navigating a complex cannabis market with a multi-pronged strategy emphasizing profitability, international expansion, and asset optimization.
- Supply-Demand Discipline: The company’s ability to flex production capacity and avoid oversupply contrasts with industry peers, supporting margin sustainability.
- International Regulatory Complexity: Expansion into diverse jurisdictions requires ongoing compliance and operational excellence to maintain market access and reputation.
- US Market Optionality: The Texas medicinal marijuana license application remains pending, with federal cannabis de-scheduling developments creating potential entry pathways.
- Capital Allocation Balance: Maintaining growth investments while managing exposure to produce operations and potential M&A opportunities.
- Product Innovation and Consumer Experience: Investments in new product formats and packaging, particularly in the Netherlands and Canada, aim to enhance brand differentiation.
Risks
Village Farms faces regulatory uncertainty, particularly in the US cannabis market, which could delay or limit expansion. Pricing pressures in Canadian retail cannabis persist, and international market growth depends on evolving legal frameworks. Execution risk exists around capacity expansions and integration of privatized produce assets. Currency fluctuations and excise tax burdens also impact profitability.
Forward Outlook
For Q3 2025, Village Farms expects continued momentum in international cannabis sales and steady performance from the Netherlands operation, with operational expenses increasing ahead of the Phase II facility launch. The company anticipates maintaining Canadian cannabis gross margins near the high end of its 30 to 40% target range.
- Q3 sales expected to be in line with Q2 levels, with growth from Netherlands ramp-up.
- Capital expenditures focused on Delta II conversion and Netherlands Phase II facility.
For full-year 2025, management projects sustained international export sales at levels comparable to the first half, with profitability improvements driven by product mix and operational efficiencies. The company remains cautious on retail pricing but confident in its disciplined supply management.
Takeaways
Village Farms’ Q2 2025 results reveal a company successfully transitioning from legacy produce operations to a focused, profitable global cannabis platform. The margin expansion in Canadian cannabis and explosive international growth validate its strategic realignment and operational discipline. Capacity expansions in Canada and the Netherlands provide a clear runway for 2026 growth, while the US market remains an important optionality with regulatory developments underway. Investors should monitor execution on these expansions, international regulatory developments, and the company’s ability to sustain pricing and margin gains amid competitive pressures.
- Profitability Focused Growth: Margin gains and positive free cash flow highlight sustainable earnings improvement.
- Global Footprint Expansion: International markets and new recreational sales in the Netherlands diversify revenue streams.
- Capital Efficiency and Balance Sheet Strength: Produce asset privatization and debt refinancing enhance financial flexibility for growth investments.
Conclusion
Village Farms delivered record profitability and margin expansion in Q2 2025, driven by a disciplined product portfolio shift, rapid international expansion, and strategic capacity growth. The company’s strong balance sheet and operational expertise position it well to capitalize on emerging cannabis market opportunities globally while managing legacy produce assets prudently.
Industry Read-Through
Village Farms’ results underscore the importance of supply-demand discipline and product portfolio optimization in the cannabis sector, particularly in mature markets like Canada. The surge in international medical cannabis exports highlights growing global demand and regulatory harmonization opportunities. The company’s approach to leveraging existing greenhouse assets for cannabis cultivation offers a capital-efficient model that peers might emulate. Additionally, the cautious but optimistic stance on US market entry reflects broader industry anticipation of federal regulatory changes, signaling potential consolidation and expansion in the near term.